This review will summarize the role of the NLRP3 inflammasome complex in the development of CA-CRC and summarize studies that report on the downregulation of NLRP3 activity, in order to develop therapeutic strategies in IBD as well as in CA-CRC. The gene discussed is NLRP3; the disease is cancer.